Nicotine Modulates CTSS (Cathepsin S) Synthesis and Secretion Through Regulating the Autophagy-Lysosomal Machinery in Atherosclerosis.
Animals
Atherosclerosis
/ drug therapy
Autophagy
/ drug effects
Basic Helix-Loop-Helix Leucine Zipper Transcription Factors
/ genetics
Cathepsins
/ biosynthesis
Cell Line
Cell Movement
/ drug effects
Disease Models, Animal
Exocytosis
Lysosomes
/ drug effects
Mechanistic Target of Rapamycin Complex 1
/ metabolism
Mice, Knockout, ApoE
Muscle, Smooth, Vascular
/ drug effects
Myocytes, Smooth Muscle
/ drug effects
Nicotine
/ pharmacology
Secretory Pathway
Signal Transduction
rab GTP-Binding Proteins
/ genetics
atherosclerosis
autophagy
cathepsin S
lysosome
nicotine
Journal
Arteriosclerosis, thrombosis, and vascular biology
ISSN: 1524-4636
Titre abrégé: Arterioscler Thromb Vasc Biol
Pays: United States
ID NLM: 9505803
Informations de publication
Date de publication:
09 2020
09 2020
Historique:
pubmed:
10
7
2020
medline:
8
10
2020
entrez:
10
7
2020
Statut:
ppublish
Résumé
Increased CTSS (cathepsin S) has been reported to play a critical role in atherosclerosis progression. Both CTSS synthesis and secretion are essential for exerting its functions. However, the underlying mechanisms contributing to CTSS synthesis and secretion in atherosclerosis remain unclear. Approach and Results: In this study, we showed that nicotine activated autophagy and upregulated CTSS expression in vascular smooth muscle cells and in atherosclerotic plaques. Western blotting and immunofluorescent staining showed that nicotine inhibited the mTORC1 (mammalian target of rapamycin complex 1) activity, promoted the nuclear translocation of TFEB (transcription factor EB), and upregulated the expression of CTSS. Chromatin immunoprecipitation-qualificative polymerase chain reaction, electrophoretic mobility shift assay, and luciferase reporter assay further demonstrated that TFEB directly bound to the We concluded that nicotine mediates CTSS synthesis and secretion through regulating the autophagy-lysosomal machinery, which offers a potential therapeutic target for atherosclerosis treatment.
Identifiants
pubmed: 32640907
doi: 10.1161/ATVBAHA.120.314053
doi:
Substances chimiques
Basic Helix-Loop-Helix Leucine Zipper Transcription Factors
0
Tcfeb protein, mouse
0
Nicotine
6M3C89ZY6R
Mechanistic Target of Rapamycin Complex 1
EC 2.7.11.1
Cathepsins
EC 3.4.-
cathepsin S
EC 3.4.22.27
Rab10 protein, mouse
EC 3.6.1.-
rab GTP-Binding Proteins
EC 3.6.5.2
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Video-Audio Media
Langues
eng
Sous-ensembles de citation
IM
Pagination
2054-2069Commentaires et corrections
Type : CommentIn